ftInvstr
MAXHEALTH · Healthcare ₹983.8 -1.07% Mkt Cap ₹96023 Cr fair

MAXHEALTH

Healthcare Medical Care Facilities
₹983.8
-1.07% today · 30d -8.04%
as of 2026-09-04
Price · Daily Candles
“Max Healthcare: DIIs muscle up as FIIs trim holding amidst price dip.”
Max Healthcare reported robust annual revenue growth of 19.14% and profit growth of 34.07% for the year ended March 31, 2026. However, its stock price has dropped -14.91% over the last year, coinciding with FIIs shedding 5.16% of their stake last quarter, while DIIs absorbed this, increasing their holdings by 5.12%.
BULL CASE
+Annual revenue for FY26 grew by 19.14% to ₹8373 Cr, with net profit up 34.07% to ₹1442 Cr.
+Quarterly revenue for Q4FY26 increased by 12.21% YoY to ₹2143 Cr, with operating profit up 17.14% to ₹654 Cr.
+The company maintains a high profitability score of 85, with an operating profit margin of 29.87% in Q4FY26.
+Forecasts indicate strong sales growth, with ML sales predicts ranking strong (0.778 for 1Y recent 2Y, 0.748 for 1Y rolling 4Y, 0.77 for 1Y stable 7Y).
BEAR CASE
The stock price has seen significant declines: -14.91% over the last year and -6.85% in the past week, with a 9.76% proximity to its 52-week low.
FIIs decreased their stake by 5.16% QoQ to 45.39% in the March 2026 quarter.
The TTM PE ratio stands at 67.57, while the PB ratio is 9.68, indicating a stretched valuation score of 20.
ML predictions show a weak rank for FCF growth (0.144 for 1Y recent 2Y, 0.168 for 1Y rolling 4Y, 0.097 for 1Y stable 7Y).
⟳ What Changed
₹ Latest Earnings · Q ending 2026-06-30
REVENUE
₹2366 Cr
+16.7% YoY
NET PROFIT
₹323 Cr
+4.87% YoY
OPM
26.55%
-0.55pp YoY
EPS
₹3.32
PE 67.57
Intrinsic value · DCF ₹849.17 · Margin of safety -13.7% (fair) · FCF yield 0.15%
◇ Sector Position
Max Healthcare's TTM PE of 67.57 is positioned below sector leader Fortis (94.26) but above NH (47.68), while its ROCE of 15.0% trails peers like Apollo Hospitals (20.26%) and NH (22.72%).
PEERPEROCE %
MAXHEALTH67.5715.0
APOLLOHOSP82.1320.26
FORTIS94.2613.4
ASTERDM100.9103.54
+ 2 more peers — sign in to view
ML Forward Growth Predictions 🔒

9 ML-predicted forward-growth ranks across sales, EBIT, and FCF.

Sign up freeSign in
58
SCORE / 100
Overall
6-axis composite of the sections below.
Performance NEUTRAL 40
Valuation STRETCHED 20
Growth STRONG 78
Profitability HIGH 85
Technicals WEAK 48
Risk LOW 80
Key Stats
TTM PE
67.57
P/B
9.68
52W HIGH
₹1256.0
OFF HIGH
-21.67%
DIV YIELD
0.15%
MKT CAP
₹96023 Cr
◉ Active Signals
MACDNeutral0.7537
RSI(14)Bearish34.9
Near 52W LowBearish8.95
Street Consensus
25 analysts
₹1151.72
mean target
Low ₹825.0Now ₹983.8High ₹1330.0
⧉ Strategy Fit 🔒

See which of ftInvstr's 50+ strategies hold MAXHEALTH and at what entry.

Sign up freeSign in